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The intracellular level of cyclic 3,5-AMP (cAMP), a signaling molecule that mediates a variety of cellular
processes, is finely modulated by the regulation of its synthesis, excretion, and degradation. In this study,
cAMP phosphodiesterase (CpdA), an enzyme that catalyzes the conversion of cAMP to AMP, was characterized
in a pathogenic bacterium, Vibrio vulnificus. The cpdA gene exists in an operon composed of mutT, yqiB, cpdA,
and yqiA, the transcription of which was initiated at position 22 upstream of mutT. A cpdA-null mutant of V.
vulnificus contained significantly higher levels of cAMP than the wild type but showed no detectable cAMP
when a multicopy plasmid of the cpdA gene was provided in trans, suggesting that CpdA is responsible for
cAMP degradation. Cellular contents of the CpdA protein decreased dramatically in both cya and crp mutants.
In addition, levels of expression of the cpdA::luxAB transcription fusion decreased in cya and crp mutants. The
level of expression of cpdA::luxAB in the cya mutant increased in a concentration-dependent manner upon the
exogenous addition of cAMP. The cAMP-cAMP receptor protein (CRP) complex bound directly to the up-
stream region of mutT, which includes a putative CRP-binding sequence centered at position 95.5 relative to
the transcription start site. Site-directed mutagenesis or the deletion of this sequence in the cpdA::luxAB
transcription fusion resulted in the loss of regulation by cAMP and CRP. Thus, this study demonstrates that
CpdA plays a crucial role in determining the intracellular cAMP level and shows for the first time that the
expression of cpdA is activated by the cAMP-CRP complex via direct binding to the regulatory region.
The pathogenic bacterium Vibrio vulnificus is a normal in-
habitant of marine estuary environments and infects humans
via ingestion of seafood or contact with seawater. Thus, the life
cycle of this pathogen involves periods of stress when environ-
mental parameters are fluctuated (25). V. vulnificus must sur-
vive such conditions and be able to proliferate with high
metabolic activity when the proper host conditions are en-
countered to cause fatal septicemia or gastroenteritis (32).
This bacterium is therefore expected to be able to sense the
fluctuations in the surrounding environment and to respond to
conditions in its physicochemically distinct niches.
Cyclic 3,5-AMP (cAMP) is a cellular signaling metabolite
that is involved in relieving the carbon catabolite repression of
many genes and operons that encode diverse catabolic en-
zymes (10). It also mediates multiple global regulatory net-
works by controlling the expression of major transcription fac-
tors in a variety of microorganisms (4, 11). For example,
bacterial global regulators such as sigma factor S (RpoS) or
ferric uptake regulator (Fur) have been shown to be regulated
by cAMP complexed with another global regulator, cAMP
receptor protein (CRP), which is itself regulated by cAMP (9,
13, 20). Recently, the cAMP-CRP complex has been reported
to be involved in the regulation of numerous virulence factors
in pathogenic bacteria. The production of the potent virulence
factors of pathogenic Vibrio species, cholera toxin (ctxAB) and
toxin-coregulated pilus (tcpPH) in Vibrio cholerae (31) and
metalloprotease (vvpE) and cytolytic hemolysin (vvhBA) in V.
vulnificus (2, 8, 14), has been shown to be regulated by the
cAMP-CRP complex. Thus, it has been suggested that cAMP
is one of the key molecules for the timely expression of viru-
lence factors in pathogenic bacteria (10).
Microorganisms are required to modulate cAMP levels to
mediate various cellular processes in response to physiological
demands (19). The final intracellular concentration of cAMP is
determined by a fine-tuned regulatory system that includes its
synthesis by adenylate cyclase, its extracellular excretion, and
its cleavage into 5-AMP by 3,5-cAMP phosphodiesterase (5,
28). Although we have extensive knowledge about the synthe-
sis and excretion of cAMP (5), the enzymatic hydrolysis of
cAMP and the genes encoding these enzymes have been stud-
ied in only a limited number of bacterial species. The genes
encoding the cytoplasmic 3,5-cAMP phosphodiesterase
(CpdA) have been isolated and characterized for only two
bacterial species so far, Escherichia coli (12) and Haemophilus
influenza (23). Studies of some bacterial species, including E.
coli (12), Salmonella enterica serovar Typhimurium (4), Brady-
rhizobium japonicum (7), and Myxococcus xanthus (18), indi-
cate that the CpdA proteins are involved in decreasing intra-
cellular cAMP levels. The regulation of cpdA expression,
however, has not yet been studied.
We have isolated the cpdA gene from the genomic library of
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V. vulnificus (GenBank accession number AY221025) (20).
When the putative amino acid sequence of V. vulnificus CpdA
was aligned with those deduced from the corresponding genes
of E. coli (GenBank accession number BAA03986.1) and H.
influenzae (GenBank accession number NP_438561.1), it
showed significant identities of 51 and 45%, respectively (see
Fig. S1 in the supplemental material). In the present study, we
investigated the role of this gene product in determining in-
tracellular cAMP levels and examined the regulation of cpdA
gene expression in V. vulnificus.
MATERIALS AND METHODS
Strains, plasmids, and culture cultivation. The strains and plasmids used in
this study are listed in Table 1. E. coli strains used for plasmid DNA preparation
and conjugational transfer were grown at 37°C in Luria-Bertani (LB) medium
supplemented with appropriate antibiotics. V. vulnificus strains were grown in LB
medium supplemented with an additional 1.5% (wt/vol) NaCl (LBS) at 30°C
unless stated otherwise. All medium components were purchased from Difco,
and chemicals and antibiotics were obtained from Sigma.
Determination of cAMP concentrations. Wild-type and cya and cpdA mu-
tant V. vulnificus strains were grown in LBS. The cpdA mutant carrying either
a broad-host-range vector (pLAFR5) (16) or cpdA-containing pLAFR5 (pHS51)
was grown in LBS supplemented with 3 g/ml tetracycline. Exponential-phase
(the optical density at 595 nm [OD595] ranged from 0.6 to 0.7) and stationary-
phase (the OD595 ranged from 3.3 to 4.0) cells were harvested and lysed, and
the amount of cAMP in the lysates was estimated using the cAMP Biotrak
enzyme immunoassay system according to the manufacturer’s instructions (Am-
ersham). To determine concentrations of secreted cAMP, the same procedure
was applied to cell-free spent medium, which had been filtered through a 0.22-
m-pore-size membrane.
Western blot analysis of CpdA. A pair of oligonucleotides, cpdAexp-F (5-C
CCGGATCCTTGCAACATACATCCAGTGATACG-3 [underlined sequence
indicates a BamHI restriction site]) and cpdAexp-R (5-GGGCTGCAGTTAG
GACGGCTCATATCAGTAACC-3 [underlined sequence indicates a PstI re-
striction site]), were used to amplify an 840-bp DNA fragment containing the full
sequence of the cpdA open reading frame (ORF) from the genomic DNA of V.
vulnificus. Recombinant CpdA (rCpdA) was overexpressed in E. coli JM109 cells
carrying pQE30-cpdA with His6-tagged CpdA and purified using a Ni-nitrilotri-
acetic acid affinity column as directed by the manufacturer (Qiagen). Purified
rCpdA was used to generate polyclonal antibodies by three immunizations of
Sprague-Dawley rats (200 g of CpdA protein per immunization) at 3-week
intervals. Cell lysates of wild-type and cpdA, crp, and cya mutant V. vulnificus
were prepared by sonication in TNT buffer (10 mM Tris-HCl, 150 mM NaCl, and
0.05% [vol/vol] Tween 20 [pH 8.0]) (29). One hundred micrograms of each
bacterial lysate was fractionated by sodium dodecyl sulfate (SDS)-polyacryl-
amide gel electrophoresis and transferred onto a Hybond P membrane (Amer-
sham). The membrane was incubated with polyclonal antibodies against rCpdA
(1:5,000 dilution) and then incubated with alkaline phosphatase-conjugated rab-
bit anti-rat immunoglobulin G (1:5,000; Sigma). Immunoreactive protein bands
were visualized using a nitroblue tetrazolium-BCIP (5-bromo-4-chloro-3-in-
dolylphosphate) system (Promega). To investigate the effect of added cAMP on
CpdA levels, cAMP was added to the cya mutant at a final concentration of 1.0
mM for 1.5 h before extracts were prepared.
Northern blot analysis. Total RNA was extracted from wild-type V. vulnificus
ATCC 29307 cells using Trizol reagent (Gibco BRL) according to the manufac-
turer’s instructions and quantified by spectrophotometric readings at 260 nm.
Thirty micrograms of RNA was fractionated by 1% formaldehyde agarose gel
electrophoresis in a running buffer (0.1 M MOPS [morpholinepropanesulfonic
acid], 40 mM sodium acetate, and 5 mM EDTA), blotted onto a Hybond-N
membrane (Amersham) by capillary transfer in 20 SSPE (3 M NaCl, 0.2 M
NaH2PO4, 0.02 M EDTA), and immobilized using a UV cross-linker (CL-1000;
UVP). Blots were incubated for 2 h at 42°C in a prehybridization solution (5
SSPE, 50% formamide, 5 Denhardt’s solution, 0.5% SDS, 200 g/ml salmon
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Relevant characteristic(s) Source orreference
Strains
V. vulnificus
ATCC 29307 Clinical isolate; virulent 14
AR ATCC 29307 but spontaneous rifampin resistance 26
HY101 AR but cpdA 20
KP301 AR but cya 20
KC74 ATCC 29307 but crp::nptI 14
E. coli
DH5 (80 lacZM15) recA1 endA1 gyrA96 relA1 thi-1 hsdR17(rK
	 mK
	) supE44 deoR
(lacZYA-argF)U169
Laboratory
collection
SM10
pir thi-1 thr leu tonA lacY supE recA::Rp4-2-Tc::Mu
pir; OriT of RP4; Kmr 30
JM109 endA1 recA1 gyrA96 thi-1 hsdR17(rK
	 mK
	) relA1 supE44 (lac-proAB) F traD3
6proAB lacIqZM15
Promega
Plasmids
pUC19 Cloning vector; lacZ Apr 34
pINE45 pUC19 with 1.72-kb Sau3AI fragment of V. vulnificus DNA containing the cpdA gene This study
pINE45-1 pUC19 with 4.3-kb Sau3AI fragment of V. vulnificus DNA containing the cpdA gene This study
pLAFR5 IncP Tcr; derivative of pLAFR3 containing double cos cassettes 16
pHS51 pLAFR5 containing EcoRI and HindIII fragment of pINE45 This study
pQE30 Expression vector; Apr Qiagen
pQE30-cpdA pQE30 with V. vulnificus cpdA This study
pHK0011 Transcriptional fusion plasmid with promoterless luxAB; Tcr 8
pSMK-cpdA-1 pHK0011 with cpdA upstream region (positions 	1521 to 41 relative to cpdA IC) This study
pSMK-cpdA2 pHK0011 with cpdA upstream region (positions 	1178 to 	1051 relative to cpdA IC) This study
pSMK-cpdA3 pHK0011 with cpdA upstream region (positions 	1163 to 	1051 relative to cpdA IC) This study
pGEM-11zf() General cloning vector; Apr Promega
pGEM-11zf()-cpdA2mt pGEM-11zf() with the mutagenized sequence for the putative CRP-binding site of
cpdA regulatory region
This study
pSMK-cpdA2mt pSMK-cpdA2 but mutagenized CRP-binding site This study
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sperm DNA, and 10% dextran sulfate). Hybridization at 42°C was continued
overnight in the presence of a labeled cpdA probe. For the preparation of the
probe, cpdA gene-containing plasmid pINE45 was digested with EcoRI and
HindIII, and the 1.7-kb inserted DNA fragment was isolated using the Gene-
Clean kit (Bio101) and labeled with [-32P]ATP using a Random Primer kit
(Takara). The membrane was washed twice with 2 SSPE–0.1% SDS at room
temperature for 15 min and twice with 0.1 SSPE–0.5% SDS at 60°C for 30 min
and then exposed to X-ray film (29).
Primer extension analysis. A primer, yqiE-R (5-TTCGATCACATTGCTCC
ACC-3), was designed to be complementary to positions 	976 to 	956 with
respect to the initiation codon (IC) of cpdA. The primer was labeled at the 5
terminus with [-32P]ATP using T4 polynucleotide kinase (Takara), annealed to
150 g RNA in hybridization buffer (10 mM Tris-HCl, 1 mM EDTA, 1.25 M KCl
[pH 8.0]), and then incubated at 65°C for 3 min. RNA was converted to cDNA
with SuperScript II reverse transcriptase (Invitrogen). The resultant cDNA prod-
ucts were precipitated and resolved on a sequencing gel beside sequencing
ladders generated with the same primer used for primer extension. The sequence
of pINE45-1 was determined using the dideoxy chain termination method using
AccuPower DNA sequencing kit (Bioneer) as previously described (27). Se-
quencing gels were dried and then visualized with a phosphorimager (Personal
Molecular Imager FX; Bio-Rad).
Complementation of the cpdA gene. An intact cpdA gene was isolated as EcoRI
and HindIII from pINE45, a pUC19-based plasmid with a 1.72-kb Sau3AI
fragment of V. vulnificus ATCC 29307 genomic DNA including the coding
sequence of cpdA. The cpdA-containing DNA fragment was cloned into EcoRI-
and HindIII-digested pLAFR5 to produce pHS51. The resultant plasmid in E.
coli SM10 
pir was transferred into the cpdA mutant (HY101) (20) by conju-
gation, and exconjugants were selected on TCBS (thiosulfate-citrate-bile salts-
sucrose) agar containing tetracycline.
Construction of the cpdA::luxAB transcriptional reporter fusions. A set of
cpdA::luxAB fusions was made by subcloning DNA fragments encompassing
upstream regions of the cpdA gene into pHK0011, which contains promoterless
luxAB genes (8). To construct a transcriptional fusion, pSMK-cpdA-1, a DNA
fragment containing the whole upstream region of the cpdA gene up to the 3 end
of the tolC gene, was obtained by PCR using primers SMK-F1K (5-GCGGTA
ATAAGGTACCACGG-3 [underlining indicates a KpnI site]) and SMK-RX-1
(5-GCTCTAGAATACTGTTCTCGCTGAGCG 3 [underlining indicates an
XbaI site]), digested with KpnI and XbaI, and ligated into KpnI/XbaI-digested
pHK0011. The resulting plasmid includes the region from positions 	1,521 to
41 relative to the IC of V. vulnificus cpdA. The PCR product amplified with
primers SMK-F2K (5-GGGGTACCGTCCAGTTGTGCAATAAATG-3 [un-
derlining indicates a KpnI restriction site]) and SMK-RX (5-AGAACCTCTA
GATCTTCTGG-3 [underlining indicates an XbaI restriction site]) was cloned
into pHK0011 to produce pSMK-cpdA2, which includes only the intergenic
space between tolC and mutT (positions 	1178 to 	1051 relative to the cpdA
IC). pSMK-cpdA3 was constructed by inserting the DNA encompassing posi-
tions 	1163 to 	1051 relative to the cpdA IC that was amplified using SMK-F3K
(5-GGGGTACCAAATGAATTGTTTAAACCTAAA-3 [underlining indi-
cates a KpnI restriction site]) and SMK-RX.
The cpdA::luxAB reporters were then mobilized into the wild type and the
cpdA, crp, and cya V. vulnificus mutants via conjugal transfer. Cultures of
bacterial cells grown overnight (16 to 18 h) that contained the reporters were
inoculated into fresh LBS medium with tetracycline (3 g/ml) and grown to
stationary phase. At various time points, a portion of the samples was diluted
100-fold with LBS medium. Expression from various lengths of the cpdA up-
stream region was measured by monitoring light production in the presence of
0.006% (vol/vol) n-decyl aldehyde using a luminometer (TD-20/20; Turners
Designs). Light production was expressed in arbitrary relative light units (RLU),
and the specific bioluminescence was calculated by normalizing RLU with cell
mass (OD595) as described previously (26). cAMP at concentrations up to 1.0
mM was added exogenously to the cya mutant culture, and light emission was
monitored.
Site-directed mutagenesis of the cpdA promoter. Based on the CRP-binding
consensus sequence (AAATGTGATCTAGATCACATTT) (6), a putative CRP-
binding site, 5-AGTTGTGCAATAAATGAATTGT-3, was found in the up-
stream region of the promoter for the mutT-yqiB-cpdA-yqiA operon. This site was
mutagenized using the GeneEditor in vitro site-directed mutagenesis kit (Pro-
mega). Briefly, a DNA fragment containing the cpdA promoter region in pSMK-
cpdA2 (see above) was cloned into pGEM-11zf() to produce pGEM-11zf()-
cpdA2. Next, cpdA-siteF (5-GGGGTACCGTCCCGTAAAACAAAAAATGA
ATTGTTTAAACC-3 (underlining indicates the r mutagenesis site, and italics
indicate a KpnI site]) was used to substitute six bases in the putative CRP-
binding site. The resultant plasmid was named pGEM-11zf()-cpdA2mt. The
insert DNA of pGEM-11zf()-cpdA2mt was isolated after digestion with KpnI
and XbaI and inserted into pHK0011 to produce pSMK-cpdA2mt.
Electrophoretic mobility shift assay. The V. vulnificus rCRP protein was over-
expressed in E. coli BL21 carrying pHK0201 (15), a pRSETA (Invitrogen)-based
expression plasmid, and purified by Ni-nitrilotriacetic acid affinity chromatogra-
phy according to the manufacturer’s instructions (Qiagen). The 373-bp upstream
region of the mutT gene was PCR amplified using SMK-F1K and SMK-R2X
(5-GCTCTAGACTCAAAGGACATTGCTC-3) and labeled with [-32P]ATP
using T4 polynucleotide kinase. The labeled DNA fragment (225 nM) was
incubated with various concentrations of purified rCRP protein (50 to 200 nM)
for 30 min at 37°C in a 20-l reaction mixture containing 1 binding buffer (26)
with 500 M cAMP (Sigma). Following the addition of 3 l of loading buffer, the
samples were separated on a 6% nondenaturing polyacrylamide gel. For com-
petition analyses, the identical but unlabeled sequence was included as a com-
petitor. Competitor DNA from 22.5 to 675 nM was added to reaction mixtures
containing 225 nM of labeled DNA prior to the addition of 200 nM CRP. A
378-bp DNA fragment encompassing the promoter of the gap gene, encoding
glyceraldehyde-3-phosphate dehydrogenase, was amplified from V. vulnificus
genomic DNA using primers gap-F (5-CATTAATCTAGATATCGTCG-3)
and gap-R (5-AATCAGTGGATCCAAAGCGC-3) and included as nonspe-
cific DNA in the binding assay.
RESULTS
Genetic organization of the cpdA gene in V. vulnificus. V.
vulnificus genomic library plasmids containing the cpdA gene,
pINE45 and pINE45-1, were obtained from a screening exper-
iment to isolate the factors for which gene products caused the
change in rpoS gene expression (20). Sequencing of insert
DNA in these plasmids revealed the flanking regions of the
cpdA gene. The upstream region of the cpdA gene contains two
ORFs homologous to mutT and yqiB of E. coli that are tran-
scribed in the same direction as cpdA (Fig. 1A). Further up-
stream, an ORF homologous to the tolC gene of E. coli was
found, which is transcribed in the opposite direction from
mutT-yqiB-cpdA. An ORF downstream of cpdA is homologous
to E. coli yqiA. Downstream and in the opposite direction of
the mutT-yqiB-cpdA-yqiA gene cluster, an ORF homologous to
the topoisomerase gene is present.
Identification of the cpdA promoter. To define the promoter
of the cpdA gene, two experiments were performed. Northern
blotting using a cpdA gene probe showed the presence of a
single band approximately 2.5 kb long (Fig. 1B). Because the
cpdA gene seems to be organized as an operon composed of
mutT, yqiB, cpdA, and yqiA, this suggested that the cpdA gene
was transcribed with its flanking genes from a promoter up-
stream of the first gene, mutT. To test this hypothesis, two
different cpdA::luxAB transcriptional reporter fusions were
constructed: pSMK-cpdA-1 includes the whole upstream re-
gion of the cpdA gene to the 3 end of the tolC gene, and the
other, pSMK-cpdA2, includes only the intergenic space be-
tween tolC and mutT (Fig. 1A). Both fusions were highly ex-
pressed compared to the luciferase activity from the vector
plasmid without an insert DNA and showed exactly the same
expression pattern and level of luciferase activity (Fig. 1C),
indicating that the cpdA gene is a member of the mutT-yqiB-
cpdA-yqiA operon, and its transcript is produced as a polycis-
tronic mRNA.
The transcription start site for the mutT-yqiB-cpdA-yqiA
operon was determined by primer extension (Fig. 2A) to be at
position 	22 relative to the IC of mutT (Fig. 2B). The putative
promoter showed the presence of relatively well-conserved
	10 and 	35 regions (TAAACT and TTGAGT, respectively).
In addition, a sequence homologous to the CRP-binding con-
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sensus sequence (5-AAATGTGATCTAGATCACATTT-3)
(6) was discernible at position 	95.5 relative to the transcrip-
tion start site.
Role of CpdA in modulating cellular cAMP levels. To inves-
tigate the function of CpdA, the level of cellular cAMP of a V.
vulnificus cpdA mutant (20) was compared to that of the
wild-type strain and a cya mutant deficient in the cAMP-
synthesizing enzyme adenylate cyclase. The intracellular con-
centrations of cAMP in wild-type cells grown in LBS medium
at exponential and stationary phases were 26 and 6.3 pmol/mg
protein, respectively (Table 2). The cya mutant had nonde-
tectable levels of cAMP in both growth phases. In contrast, the
cpdA mutant showed highly elevated levels of cellular cAMP,
estimated at 99 to 137 and 37 to 45 pmol/mg protein from
exponential- and stationary-phase cells, respectively. When the
intact cpdA gene was introduced into the cpdA mutant on the
multicopy plasmid pHS51, its intracellular cAMP level de-
creased to below the detection limit.
Similarly, the level of extracellular cAMP in cell-free spent
medium from wild-type and cpdA mutant cultures was also
determined. Spent medium sampled from the cpdA mutant
culture showed a 1.7-fold-higher concentration of cAMP than
that of the wild type (S.-M. Kim and K.-H. Lee, unpublished
data). This implied that the higher intracellular cAMP level in
the cpdA mutant was not from a reduced excretion of cAMP
but possibly from an absence of cAMP phosphodiesterase ac-
tivity. Therefore, this suggests that CpdA controls the level of
intracellular cAMP through degradation.
Contents of CpdA in wild-type, cyamutant, and crpmutant
V. vulnificus strains. Since V. vulnificus CpdA appears to de-
FIG. 1. Genetic organization and transcription of the mutT-yqiB-
cpdA-yqiA operon in V. vulnificus. (A) Based upon the genetic orga-
nization of the cpdA gene, two different cpdA::luxAB transcriptional
fusions were constructed: one (pSMK-cpdA2) includes the upstream
region of mutT, the first gene of the tentative operon, and the other
(pSMK-cpdA-1) includes the entire upstream region of cpdA. (B) For
Northern blot analysis of cpdA mRNA, total RNA extracted from
stationary-phase V. vulnificus cells was hybridized with a 32P-labeled
cpdA probe and visualized by autoradiography. The left lane (lane 1)
is ethidium bromide-stained total RNA from wild-type V. vulnificus in
a formamide agarose gel, and the right lane (lane 2) is a Northern
hybridization using the cpdA probe. Arrows and numbers on the left
side indicate the molecular sizes of 23S and 16S RNAs in kilobases
(kb). (C) Wild-type V. vulnificus carrying each fusion or the vector only
(pKH0011) was grown in LBS medium supplemented with 3 g/ml
tetracycline, aliquots were sampled, and their cell masses (OD595) and
their bioluminescence (RLU) were determined. Luciferase activities
are expressed as normalized values that were obtained by dividing the
RLU by the OD595 of each sample. The averages of three independent
experiments are shown, along with their standard deviations.
FIG. 2. Determination of the transcriptional start site of the cpdA gene. (A) Primer extension using V. vulnificus RNA and oligonucleotide
primer yqiE-R (annealing to positions 130 to 150 relative to the IC of mutT). Lanes C, T, A, and G represent sequencing ladders of pINE45-1.
The 1 indicates the site of transcriptional initiation. (B) Sequence of the upstream region of mutT, the first gene of the operon composed of mutT,
yqiB, cpdA, and yqiA. The initiation codon for mutT is in boldface type, and the promoter and the putative 	10 and 	35 regions are underlined.
The putative binding site for the cAMP-CRP complex is designated with a box. The primers used for the construction of the cpdA::luxAB
transcription fusions are indicated with horizontal arrows.
TABLE 2. Intracellular cAMP contents in various V. vulnificus
strains grown in LBS medium
Growth phase
cAMP concn (pmol/mg protein) (SD)a
Wild type cya cpdA cpdA(pLAFR5)
cpdA
(pHS51)b
Exponentialc 26.2 (3.6) ND 98.8 (7.1) 137.3 (16.7) ND
Stationaryd 6.3 (0.8) ND 36.5 (0.2) 44.7 (0.7) ND
a Intracellular cAMP concentration (moles of cAMP in the unit mass of
bacterial cells determined by the protein amount in lysate) was expressed as an
average value from four independent experiments, with the standard deviation in
parentheses. ND, the cAMP concentration was not detectable because it was
below the detection limit of the assay used in this study.
b A broad-host-range vector, pLAFR5-based plasmid DNA including the V.
vulnificus cpdA gene.
c V. vulnificus cells freshly grown in LBS medium at an OD595 ranging from 0.6
to 0.7.
d V. vulnificus cells grown in LBS medium at an OD595 ranging from 3 to 4.
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grade cellular cAMP via a cAMP phosphodiesterase activity, as
is seen in other bacteria (12, 23), the effect of the substrate
cAMP on the level of the CpdA protein was examined. West-
ern blotting using polyclonal anti-CpdA antibodies produced
an immunoreactive band of 30.5 kDa in all V. vulnificus
strains except the cpdA mutant (Fig. 3A). Interestingly, the
cya mutant, which does not contain detectable levels of
cAMP (Table 2), showed significantly decreased levels of
CpdA compared to those of the wild type. Densitometric quan-
tification of immunoreactive bands indicated about a threefold
decrease in levels in the cya mutant (Fig. 3B). This suggested
that cAMP may play a role in inducing the production of an
enzyme that uses cAMP as a substrate. cAMP induction is
known to be associated with CRP (19), so the CpdA content
was also measured in a V. vulnificus crp mutant. The crp mutant
showed a CpdA level similar to that of the cya mutant. In
addition, the crp cya double mutant showed essentially the
same pattern as that of each single mutant (data not shown),
which suggested that cpdA expression is activated by the
cAMP-CRP complex.
Effect of cAMP and CRP on cpdA gene expression. Because
the upstream region of the mutT-yqiB-cpdA-yqiA operon in-
cludes a putative CRP-binding site (Fig. 2B) and the cya and
crp mutants contained less CpdA protein than did the wild type
(Fig. 3), the effect of cAMP on cpdA gene expression was
further confirmed using a transcriptional reporter fusion. The
cpdA::luxAB transcriptional fusion pSMK-cpdA2 showed re-
duced levels of expression in the cya or crp mutant, which
were about three- to fourfold lower than the levels of expres-
sion in the wild type (Fig. 4). The degree of the decrease in the
level of transcription fusion expression in the cya or crp mu-
tant was similar to the extent of the decrease in the level of the
CpdA protein in the same mutants as shown in Fig. 3.
To investigate whether the lowered level of expression of
pSMK-cpdA2 in the cya mutant was caused by the absence of
cAMP, various concentrations of cAMP were added, and the
level of expression of pSMK-cpdA2 was measured after 1.5 h
(Fig. 5A). The level of expression increased in a dose-depen-
dent manner, with maximal expression observed in the cya
mutant incubated with 0.5 mM cAMP. In a subsequent ex-
periment, cAMP was exogenously added to the cya mutant
carrying pSMK-cpdA2. In the presence of 1.0 mM cAMP in
the medium, the mutant expressed the fusion at increasingly
higher rates than the control in a time-dependent manner,
peaking at 2 h after the addition of cAMP (Fig. 5B). Similarly,
1.0 mM cAMP was exogenously added to either the wild type
or the cya mutant, and their cellular levels of CpdA protein
were compared. A Western blot using polyclonal antibodies
against rCpdA showed that the wild type was not influenced by
the exogenous addition of cAMP, but the cya mutant showed
higher levels in the presence of added cAMP (Fig. 5C). All of
the above-described results suggest that the cellular amount of
CpdA is regulated at the transcriptional level via cAMP-CRP
complex-mediated activation.
Direct interaction of the cAMP-CRP complex with the reg-
ulatory region of cpdA. The above-described results clearly
indicate that both cAMP and CRP positively affect cpdA ex-
pression. To determine whether the cAMP-CRP complex acts
by binding to the regulatory region of the mutT-yqiB-cpdA-yqiA
operon, an electrophoretic mobility shift assay was performed
using the V. vulnificus CRP protein and a 373-bp DNA encom-
passing the region used for the construction of pSMK-cpdA2.
As shown in Fig. 6, the addition of CRP and cAMP resulted in
a slower mobility of the DNA fragment in a dose-dependent
manner. The binding of cAMP-CRP to the DNA was specific,
because excess unlabeled DNA abolished the formation of the
slower-moving band, although retarded mobility was retained
FIG. 3. Cellular contents of the cAMP phosphodiesterase (CpdA)
in wild-type (wt), crp mutant, and cya mutant strains of V. vulnificus.
(A) Lysates of V. vulnificus strains grown to stationary phase (OD595 of
1.5) were used to estimate CpdA levels by Western blotting. One
hundred micrograms of each bacterial lysate was fractionated by SDS-
polyacrylamide gel electrophoresis. The blotted membrane was incu-
bated with polyclonal antibodies raised against the recombinant CpdA
and then incubated with alkaline phosphatase-conjugated rabbit anti-
rat immunoglobulin G. Upon incubation with the nitroblue tetrazolium-
BCIP system, the CpdA protein appeared as an immunoreactive band
as indicated by an arrow. (B) The intensities of bands corresponding to
CpdA were estimated by densitometry, and the densitometric readings
are presented in the plot as values relative to those of CpdA of the
wild-type strain.
FIG. 4. Effects of crp or cya mutations on expression of cpdA::
luxAB transcription fusion. Wild-type (wt), crp, and cya V. vulnificus
strains carrying pSMK-cpdA2 were grown to stationary phase in LBS
medium supplemented with 3 g/ml tetracycline, and aliquots were
sampled and measured for cell mass (OD595) and bioluminescence
(RLU). Luciferase activities are expressed as normalized values by
dividing the RLU by the OD595 of each sample. The activities of two
independent experiments were averaged and are shown with their
standard deviations. An asterisk indicates P values less than 0.005.
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in the presence of an unrelated sequence, namely, the V. vulni-
ficus gap promoter.
Site-directed mutagenesis of the CRP-binding site at the
regulatory region of cpdA. The sequence of the upstream region
of the mutT-yqiB-cpdA-yqiA operon was analyzed for the cAMP-
CRP-binding sequence. A region with considerable homology to
the E. coli CRP-binding site (AAATGTGATCTAGATCACA
TTT; underlining indicates highly conserved residues) was found
in the upstream region centered at position 	95.5 relative to the
transcription start site (Fig. 3B). To determine whether the pu-
tative binding site plays a role in cpdA transcription, the site was
modified by either site-directed mutagenesis or the deletion of the
first 11 out of 22 nucleotides of the putative CRP-binding site
(Fig. 7A and B). The altered DNAs were used to construct the
luxAB transcriptional fusions. pSMK-cpdA2mt is the same as
pSMK-cpdA2 but includes the mutated CRP-binding site. pSMK-
cpdA3 is missing 15 nucleotides at the 5 end of the pSMK-cpdA2
insert.
These mutant fusions showed similar basal levels of expres-
sion in the wild-type, crp, and cya strains (Fig. 7C and D)
compared to the level of pSMK-cpdA2 expression in the crp
and cya strains. In addition, to verify if cAMP-CRP binding
to this putative site occurs, the DNA fragment used in Fig. 6
and the same DNA but with the mutagenized putative CRP-
binding site were used for electrophoretic mobility shift assays.
No binding of cAMP-CRP to the mutagenized probe was ob-
FIG. 6. Binding of the cAMP-CRP complex to the upstream
region of the mutT-yqiB-cpdA-yqiA operon. A gel shift assay was
performed to determine the direct interaction between cAMP-CRP
and the upstream region of the mutT gene. A 32P-labeled 373-bp
DNA probe of the upstream region (225 nM) was incubated with
increasing amounts of CRP up to 200 nM in the presence of cAMP
(1.0 mM). The reaction mixtures were then subjected to 6% native
polyacrylamide gel electrophoresis. For competition analysis, the
same, but unlabeled, 373-bp DNA was included. As noncompetitive
and nonspecific DNA, an unlabeled 378-bp DNA fragment contain-
ing the promoter of the gap gene (Pgap) was added in excess. Lane
1, probe only; lane 2, probe with 50 nM CRP; lane 3, probe with 75 nM
CRP; lane 4, probe with 100 nM CRP; lane 5, probe with 150 nM CRP;
lane 6, probe with 200 nM CRP; lane 7, probe with 200 nM CRP and
22.5 nM unlabeled upstream DNA; lane 8, probe with 200 nM CRP
and 225 nM unlabeled upstream DNA; lane 9, probe with 200 nM CRP
and 675 nM unlabeled upstream DNA; lane 10, probe with 200 nM
CRP and 200 nM unlabeled Pgap DNA. The arrow on the left side
indicates the unbound DNA probe, whereas the arrow on the right side
indicates the DNA bound with CRP.
FIG. 5. Expression of cpdA in the cya mutant V. vulnificus strain in the presence of exogenous cAMP. (A) Various concentrations of cAMP
ranging from 0 to 1.5 mM were added to the cya strain carrying pSMK-cpdA2 freshly grown in LBS medium supplemented with 3 g/ml
tetracycline. After a 1.5-h incubation, specific bioluminescence was estimated as described in the legend of Fig. 4. (B) The cya strain carrying
pSMK-cpdA2 was grown in LBS medium supplemented with 3 g/ml tetracycline, and half of the culture was treated with 1.0 mM cAMP at the
time point indicated by a vertical arrow. Growth and luminescence of the mutant in the presence or absence of exogenously added cAMP were
compared. Luciferase activities are expressed as described in the legend of Fig. 4. (C) Wild-type (wt) and cya cells in exponential phase were
treated with 1.0 mM cAMP for 1.5 h and used for Western blot analysis to measure the contents of CpdA, as described in the legend of Fig. 3.
Lane 1, wild type without cAMP; lane 2, wild type with cAMP; lane 3, cya strain without cAMP; lane 4, cya strain with cAMP.
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FIG. 7. Effect of mutating the putative CRP binding site on cpdA expression. (A) A putative CRP-binding site, based upon the conserved
nucleotide sequences for CRP binding in E. coli (6), was found in the upstream region of mutT centered at position 	95.5 upstream of the
transcription start site (designated with a 1) and indicated as an open box in the pSMK-cpdA2 fusion. The same transcription fusion with an
altered putative CRP-binding site, pSMK-cpdA2mt, was constructed by site-directed mutagenesis to change the nucleotides as shown in B (hatched
box). The upstream region of mutT in pSMK-cpdA3 has a deletion of the first 11 of the 22 nucleotides that comprise the putative CRP-binding
site. Wild-type, crp, and cya strains carrying pSMK-cpdA2mt (C) or pSMK-cpdA3 (D) were grown in LBS medium supplemented with 3 g/ml
tetracycline, and aliquots were sampled to estimate specific luciferase activities. Luciferase activities are expressed as described in the legend of
Fig. 4. (E) Assay of binding of the cAMP-CRP complex to the DNA fragments carrying the original sequence (wt probe) (the same DNA used
in Fig. 6) or the mutagenized sequence (mt probe) (as indicated in B) was performed as described in the legend of Fig. 6. Lane 1, wild-type probe
without CRP; lane 2, wild-type probe with 200 nM CRP; lane 3, mutagenized probe without CRP; lanes 4, 5, and 6, mutagenized probe with 20,
100, and 200 nM CRP, respectively. The arrow on the left side indicates the unbound DNA probe, whereas the arrow on the right side indicates
the DNA bound with CRP.
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served (Fig. 7E, lanes 3 to 6), while the wild-type probe was
efficiently bound by the cAMP-CRP complex (Fig. 6 and 7E,
lanes 1 to 2). These results suggest that cpdA expression is
activated by cAMP-CRP acting on the region between posi-
tions 	106 and 	85 relative to its transcription start site.
DISCUSSION
The activity of 3,5-cAMP phosphodiesterase has been
found to play a role in optimizing cAMP concentrations in
some bacteria, to induce the starvation response, to regulate
catabolite-sensitive operons, or to protect against a high influx
of cAMP (1, 4). Using the cpdA gene isolated from V. vulnifi-
cus, we investigated the role of CpdA with respect to modu-
lating cAMP concentrations, which may subsequently result in
an adjustment of bacterial responses to diverse stimuli and the
control of virulence factor expression within host environ-
ments.
Bacterial cells grown in LB-based media without the sugars
transported by phosphotransferase systems such as glucose did
not exhibit maximal cAMP levels when they entered stationary
phase (20, 22). cAMP levels in V. vulnificus have been esti-
mated to be approximately 20 to 50 pmol cAMP/mg of pro-
tein in the exponential phase, decreasing to about 5 pmol
cAMP/mg of protein in stationary phase (20) (Table 2). When
V. vulnificus was deficient in cAMP phosphodiesterase
(CpdA), it showed highly elevated levels of cAMP compared to
those of an isogenic wild-type strain during both exponential
and stationary phases (Table 2). The increased level of cAMP
in the cpdA mutant has also been confirmed by measuring
gene expression, which is tightly regulated by cAMP and thus
might serve as an index of the intracellular level of cAMP. For
example, the rpoS gene, encoding V. vulnificus sigma factor S,
is known to be repressed by cAMP (20). We found approxi-
mately twofold-lower levels of expression of the rpoS gene in
the cpdA mutant than in the wild type (20). When the cpdA
mutant was supplied with the intact cpdA gene, its cAMP level
was too low to be detected, similar to the cya mutant that
lacks adenylate cyclase activity (Table 2). Therefore, CpdA
appears to be an important factor in controlling the intracel-
lular concentration of cAMP in V. vulnificus.
The expression of many enzymes is induced by the presence
of their substrate molecules (33). This regulatory pattern for
catalytic enzymes prompted us to study the effect of cAMP on
the regulation of cpdA expression. cpdA expression at the tran-
scriptional level was activated by the cAMP-CRP complex
(Fig. 3 and 4). The regulatory region for cpdA includes a
sequence homologous to the E. coli CRP consensus sequence
(Fig. 2B), and we found that this sequence was bound by the
cAMP-CRP complex (Fig. 6 and 7). This site is from positions
	106 to 	85 (centered at position 	95.5) with respect to its
transcription start site, which is considered an activation site
for class III CRP-dependent promoters such as the araBAD
promoter (33). Class III promoters have been reported to
require a secondary regulator protein (e.g., the AraC protein
for the araBAD promoter) for maximal induction. Regulation
at class III promoters was also reported to involve the forma-
tion of a DNA loop (21).
Exponential-phase cells growing in LBS medium contained
higher cAMP contents (Table 2), possibly due to a lowered
expression or reduced activity of CpdA during this growth
phase. Thus, it is required to search and identify another reg-
ulator for cpdA transcription and its possible interaction with
the cAMP-CRP complex for optimal cpdA expression in V.
vulnificus, as shown in the araBAD promoter (33). It is also
possible that the presence of other factors acting at the post-
transcriptional level finely adjusts the CpdA protein content or
its enzymatic activity.
Both the Northern blot and primer extension experiments
clearly suggest that the cpdA gene is organized as an operon with
its upstream flanking genes mutT and yqiB as well as its down-
stream gene yqiA (Fig. 1 and 2). MutT is the nucleoside triphos-
phate pyrophosphohydrolase that catalyzes a conversion of de-
oxynucleoside triphosphate to deoxynucleoside monophosphate
(3). The predicted gene products of yqiB and yqiA have homology
to a hypothetical phosphohydrolase from Vibrio parahaemolyticus
(GenBank accession no. ZP_01993039.1) and a hypothetical es-
terase from Yersinia pestis (GenBank accession no. NP_404305.1),
respectively. Their functions, however, have not been determined.
Thus, it is currently not known why the cpdA gene, which encodes
an enzyme to catalyze the conversion of cAMP to AMP, is co-
regulated and coexpressed with the other three genes, although
the gene products from this operon might be involved in the
metabolism of nucleotides to produce nucleoside monophos-
phates or to remove undesired nucleotides. Further study is
needed to elucidate their biological significance.
Cyclic phosphodiesterases have been shown to be involved
in the stress response of M. xanthus against temperature and
osmotic shocks (18). The cpdA mutant V. vulnificus strain
shows additional phenotypes. For example, scanning electron
microscopy of wild-type and cpdA mutant V. vulnificus strains
revealed that the cpdA gene product is required for normal
cellular morphology (see Fig. S2 in the supplemental material).
The elongated morphology of the cpdA mutant might result
from altered expression of the genes involved in cell division
and/or cell shape caused by a failure to adjust cAMP levels (4,
5). In addition, proteomic screening of V. vulnificus proteins
required for mature biofilm formation found many proteins
whose levels of expression are expected to be regulated by the
cAMP-CRP complex (17). These results imply that deficiency
in functional CpdA results in pleiotropic effects on the patho-
genic bacterium V. vulnificus. According to data described pre-
viously by Merrell et al. (24), cpdA is one of the most important
colonization factors in V. cholerae. Therefore, it will be inter-
esting to investigate the roles of CpdA in the pathogenesis of
V. vulnificus.
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